source
- FDA staff flag peptide conflict concerns and warn drug ad rule could curb advertisingFDA staff have raised internal concerns about potential conflicts of interest among experts who will sit on an upcoming advisory panel reviewing peptide therapies. The staff memo warns that undiscl…
- Dimerix acquires Mission’s acute kidney injury candidate for $5 million upfrontDimerix announced it has signed a deal to acquire a kidney injury drug candidate from Mission Therapeutics. The asset is ready to enter Phase 2 trials for the treatment of acute kidney injury. Und…